The GLP-1 shortages are over. What happens next?
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
New ‘natural’ GLP-1 booster that can be added to any food for weight loss to hit shelves within the next year
You may soon be able to eat your Ozempic… sort of. GLP-1 supplements are booming, promising to deliver similar benefits to ...
First for Women on MSN1h
Josh Gad Lost 40 Lbs on a GLP-1 Drug, but Not Without Complications
From singing on Broadway to playing beloved characters on the big screen (including everyone's favorite animated snowman, ...
JD Supra6h
GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs
GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
Eli Lilly's first weight loss pill could expand access to GLP-1s around the globe, executive says
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
News-Medical.Net on MSN3d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients
Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
STAT2d
As GLP-1 compounding stares down a wall, telehealth companies pivot to hormones
As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Novo Nordisk to explore how GLP-1 drugs can help patients with addiction
Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst ...
Medpage Today on MSN7d
Use of GLP-1 Drugs for Obesity Linked to Lower Risk of Glaucoma
Use of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...
GLP-1 Drugs Improve Outlook For Kidney Transplants
Our findings also show that while the benefits of GLP-1 drugs are significant, their use does come with some added risk of diabetic retinopathy, suggesting that physicians need ...